BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang H, Campbell SC, Nelius T, Bedford DF, Veliceasa D, Bouck NP, Volpert OV. α1-antitrypsin inhibits angiogenesis and tumor growth. Int J Cancer 2004;112:1042-8. [DOI: 10.1002/ijc.20494] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Frenzel E, Wrenger S, Immenschuh S, Koczulla R, Mahadeva R, Deeg HJ, Dinarello CA, Welte T, Marcondes AMQ, Janciauskiene S. Acute-Phase Protein α1-Antitrypsin—A Novel Regulator of Angiopoietin-like Protein 4 Transcription and Secretion. J I 2014;192:5354-62. [DOI: 10.4049/jimmunol.1400378] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
2 He Q, Yang H, Wong BCY, Chiu J. Serological Proteomics of Gastritis: Degradation of Apolipoprotein A-I and Alpha1-Antitrypsin Is a Common Response to Inflammation Irrespective of Helicobacter pylori Infection. Dig Dis Sci 2008;53:3112-8. [DOI: 10.1007/s10620-008-0269-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Shi YY, Wang HC, Yin YH, Sun WS, Li Y, Zhang CQ, Wang Y, Wang S, Chen WF. Identification and analysis of tumour-associated antigens in hepatocellular carcinoma. Br J Cancer. 2005;92:929-934. [PMID: 15756260 DOI: 10.1038/sj.bjc.6602460] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
4 Emechebe U, Nelson JW, Alkayed NJ, Kaul S, Adey AC, Barnes AP. Age-dependent transcriptional alterations in cardiac endothelial cells. Physiol Genomics 2021;53:295-308. [PMID: 34097533 DOI: 10.1152/physiolgenomics.00037.2021] [Reference Citation Analysis]
5 Wu W, Juan WC, Liang CR, Yeoh KG, So J, Chung MC. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl. 2012;6:152-162. [PMID: 22532451 DOI: 10.1002/prca.201100050] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
6 Yang X, Bentink S, Scheid S, Spang R. Similarities of ordered gene lists. J Bioinform Comput Biol 2006;4:693-708. [PMID: 16960970 DOI: 10.1142/s0219720006002120] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
7 Ghaedi M, Soleimani M, Taghvaie NM, Sheikhfatollahi M, Azadmanesh K, Lotfi AS, Wu J. Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors. J Gene Med. 2011;13:171-180. [PMID: 21449040 DOI: 10.1002/jgm.1552] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
8 Liu X, Zhang B, McBride JD, Zhou K, Lee K, Zhou Y, Liu Z, Ma JX. Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway. Diabetes 2013;62:4228-38. [PMID: 23884893 DOI: 10.2337/db12-1710] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
9 Xu Y, Zhang J, Han J, Pan X, Cao Y, Guo H, Pan Y, An Y, Li X. Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer. Mol Oncol 2012;6:405-17. [PMID: 22507634 DOI: 10.1016/j.molonc.2012.03.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
10 Shapira MG, Khalfin B, Lewis EC, Parola AH, Nathan I. Regulation of autophagy by α1-antitrypsin: "a foe of a foe is a friend". Mol Med 2014;20:417-26. [PMID: 25105300 DOI: 10.2119/molmed.2014.00054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wanner A, Arce AD, Pardee E. Novel Therapeutic Uses of Alpha-1 Antitrypsin: A Window to the Future. COPD: Journal of Chronic Obstructive Pulmonary Disease 2012;9:583-8. [DOI: 10.3109/15412555.2012.717125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
12 Janciauskiene S, Wrenger S, Immenschuh S, Olejnicka B, Greulich T, Welte T, Chorostowska-Wynimko J. The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions. Front Pharmacol 2018;9:341. [PMID: 29719508 DOI: 10.3389/fphar.2018.00341] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
13 Huang C, Ananthaswamy HN, Barnes S, Ma Y, Kawai M, Elmets CA. Mass spectrometric proteomics profiles ofin vivo tumor secretomes: Capillary ultrafiltration sampling of regressive tumor masses. Proteomics 2006;6:6107-16. [DOI: 10.1002/pmic.200600287] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
14 Karousis N, Papi RM, Siskos A, Vakalopoulou P, Glezakos P, Sarigiannis Y, Stavropoulos G, Kyriakidis DA, Tagmatarchis N. Peptidomimetic–functionalized carbon nanotubes with antitrypsin activity. Carbon 2009;47:3550-8. [DOI: 10.1016/j.carbon.2009.08.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou X, Liu Z, Zhang J, Adelsberger JW, Yang J, Burton GF. Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes. BMC Microbiol 2016;16:172. [PMID: 27473095 DOI: 10.1186/s12866-016-0751-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
16 Guttman O, Baranovski BM, Schuster R, Kaner Z, Freixo-Lima GS, Bahar N, Kalay N, Mizrahi MI, Brami I, Ochayon DE. Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats. Clin Exp Immunol. 2015;179:161-172. [PMID: 25351931 DOI: 10.1111/cei.12476] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
17 Anes AB, Nasr HB, Hammann P, Kuhn L, Trimeche M, Hamrita B, Bougmiza I, Chaieb A, Khairi H, Chahed K. Assessment of the clinical significance of antigenic and functional levels of α1-proteinase inhibitor (α1-Pi) in infiltrating ductal breast carcinomas. Clin Biochem 2012;45:1421-31. [PMID: 22841602 DOI: 10.1016/j.clinbiochem.2012.07.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I. Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J 2009;23:3149-58. [PMID: 19423638 DOI: 10.1096/fj.09-129304] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
19 Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol 2011;6:291-5. [PMID: 21173712 DOI: 10.1097/JTO.0b013e31820213fb] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
20 Kalsheker NA. α 1 -Antitrypsin deficiency: best clinical practice. J Clin Pathol 2009;62:865-9. [DOI: 10.1136/jcp.2008.063495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
21 Dyrlund TF, Poulsen ET, Scavenius C, Nikolajsen CL, Thøgersen IB, Vorum H, Enghild JJ. Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J Proteome Res. 2012;11:4231-4239. [PMID: 22698189 DOI: 10.1021/pr300358k] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 6.5] [Reference Citation Analysis]
22 DeSouza LV, Grigull J, Ghanny S, Dubé V, Romaschin AD, Colgan TJ, Siu KW. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007;6:1170-82. [PMID: 17374602 DOI: 10.1074/mcp.M600378-MCP200] [Cited by in Crossref: 79] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
23 Bhakuni T, Ali MF, Ahmad I, Bano S, Ansari S, Jairajpuri MA. Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay. Arch Biochem Biophys 2016;604:128-42. [PMID: 27372899 DOI: 10.1016/j.abb.2016.06.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
24 Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E, Azam T, Dinarello CA, Reddy P. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 2012;109:564-9. [PMID: 22203983 DOI: 10.1073/pnas.1117665109] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 8.5] [Reference Citation Analysis]
25 Zhang B, Abreu JG, Zhou K, Chen Y, Hu Y, Zhou T, He X, Ma JX. Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci U S A 2010;107:6900-5. [PMID: 20351274 DOI: 10.1073/pnas.0906764107] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
26 Pérez-Holanda S, Blanco I, Menéndez M, Rodrigo L. Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC Cancer 2014;14:355. [PMID: 24886427 DOI: 10.1186/1471-2407-14-355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
27 Mcnulty MJ, Silberstein DZ, Kuhn BT, Padgett HS, Nandi S, Mcdonald KA, Cross CE. Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives. Free Radical Biology and Medicine 2021;163:10-30. [DOI: 10.1016/j.freeradbiomed.2020.11.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Elshikha AS, Lu Y, Chen MJ, Akbar M, Zeumer L, Ritter A, Elghamry H, Mahdi MA, Morel L, Song S. Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus. PLoS One 2016;11:e0156583. [PMID: 27232337 DOI: 10.1371/journal.pone.0156583] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
29 Lewis EC. Expanding the clinical indications for α(1)-antitrypsin therapy. Mol Med 2012;18:957-70. [PMID: 22634722 DOI: 10.2119/molmed.2011.00196] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 10.2] [Reference Citation Analysis]
30 Pott GB, Chan ED, Dinarello CA, Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009;85:886-95. [PMID: 19197072 DOI: 10.1189/jlb.0208145] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 9.2] [Reference Citation Analysis]
31 Guttman O, Freixo-Lima GS, Kaner Z, Lior Y, Rider P, Lewis EC. Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin. Front Immunol 2016;7:559. [PMID: 28003813 DOI: 10.3389/fimmu.2016.00559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
32 Bellacen K, Kalay N, Ozeri E, Shahaf G, Lewis EC. Revascularization of pancreatic islet allografts is enhanced by α-1-antitrypsin under anti-inflammatory conditions. Cell Transplant 2013;22:2119-33. [PMID: 23050776 DOI: 10.3727/096368912X657701] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
33 Guttman O, Yossef R, Freixo-Lima G, Rider P, Porgador A, Lewis EC. α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes. Immunology 2014. [PMID: 25308894 DOI: 10.1111/imm.12403] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
34 Akita N, Ma N, Okamoto T, Asanuma K, Yoshida K, Nishioka J, Shimaoka M, Suzuki K, Hayashi T. Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability. Thromb Res 2015;135:1203-8. [PMID: 25887633 DOI: 10.1016/j.thromres.2015.03.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]